9 reports

Note: ##.

  • Ovarian Cancer
  • World
  • Forecast
  • bioMerieux S.A.
  • Cepheid

It is mainly dedicated to the manufacturing and marketing of APIs and drug products of dermatology, anti-tuberculosis and oncology.

  • Ovarian Cancer
  • China
  • Demand
  • Bayer Schering Pharmaceutical Co., Ltd
  • Roche Group

It is mainly dedicated to the manufacturing and marketing of APIs and drug products of dermatology, anti-tuberculosis and oncology.

  • Ovarian Cancer
  • China
  • Demand
  • Bayer Schering Pharmaceutical Co., Ltd
  • Roche Group
  • APR 12, 2016: CELSION ANNOUNCES UPCOMING PRESENTATION AT AACR 2016 HIGHLIGHTING POTENTIAL OF GEN-1 IL-12 IMMUNOTHERAPY IN OVARIAN CANCER

The company' s project pipeline includes products with therapeutic application in the area of diabetes type II, leishmaniasis, and tuberculosis.

  • Hospital
  • Monoclonal Antibody
  • Ovarian Cancer
  • Therapy
  • OncoSec Medical Incorporated
  • CLINICAL TRIAL PROFILE. 1545 TRIAL TITLE
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Cancer
  • Chemotherapy
  • Clinical Trial
  • Ovarian Cancer
  • World

It is also developing preventive vaccines for malaria and tuberculosis, and therapeutics vaccines for cancers.

  • Hospital
  • Monoclonal Antibody
  • Ovarian Cancer
  • Therapy
  • Merck & Co., Inc.
  • EPITHELIAL OVARIAN CANCER - PIPELINE BY SANOFI PASTEUR SA, H1 2016

The drug candidate was also tested in in-vivo mouse model for tuberculosis.

  • Monoclonal Antibody
  • Ovarian Cancer
  • United States
  • Product Initiative
  • Merck & Co., Inc.
  • EPITHELIAL OVARIAN CANCER - PIPELINE BY SANOFI PASTEUR SA, H2 2016
  • EPITHELIAL OVARIAN CANCER - PIPELINE BY INNATE IMMUNOTHERAPEUTICS LTD, H2 2016

The drug candidate was also tested in in-vivo mouse model for tuberculosis.

  • Hospital
  • Ovarian Cancer
  • Targeted Therapy
  • Therapy
  • Merck & Co., Inc.
  • FALLOPIAN TUBE CANCER - PIPELINE BY SELLAS LIFE SCIENCES GROUP INC, H1 2018

Its products are used in the treatment of cholera, diphtheria, haemophilus influenzae type b infections, meningococcal infections, pertussis, pneumococcal infections, tetanus, tuberculosis, typhoid fever, hepatitis A, hepatitis B, influenza, measles, mumps, poliomyelitis and rabies.

  • Hospital
  • Monoclonal Antibody
  • Ovarian Cancer
  • Therapy
  • Merck & Co., Inc.